After a bachelor of science in biology, Jean-Baptiste will graduate with a master’s degree in pharmacology of the Sorbone University (previously University Pierre et Marie Curie [UPMC]) in Paris.

He is currently focused on new therapies link to the intestinal microbiota. During his end-of-course internship, Jean-Baptiste will work on the development of a human microbiotia model in collaboration with the Pharmacology Lab of the university of Rennes 1 (INSERM U1230).

Welcome Jean-Baptiste !


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

1 Comment

Could the microbiota be the solution to all our health problem? | HCS Pharma · March 29, 2018 at 10:00 am

[…] that can respond to their current needs. This research project is under going and realized by Jean-Baptiste Mascary who would develop human microbitota model in collaboration with the Pharmacology Lab of the […]

Leave a Reply